PRICES INCREASE $400 IN:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Delivered as a Hybrid Event
April 25 - 27, 2023The Ritz-Carlton, Tysons Corner | McLean, VAkeyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
Day One - EST (Eastern Standard Time, GMT-5)
search
Day One - EST (Eastern Standard Time, GMT-5)
search
7:15am - 8:15am60 mins
Main Conference Registration and Continental Breakfast
8:15am - 8:30am15 mins
Informa Connect Welcome and Chairperson’s Opening
- John Oroho - President & General Manager, RLDatix Life Sciences Division & Porzio Life Sciences
8:30am - 8:45am15 mins
2022 Year in Review, Presented by Potomac River Partners
8:45am - 9:30am45 mins
State of the Industry — Policy Brief on Initiatives in the Pipeline Impacting Compliance Frameworks
- John Oroho - President & General Manager, RLDatix Life Sciences Division & Porzio Life Sciences
9:30am - 10:15am45 mins
Chief Compliance Officer Luminary Panel
- Jeff Rosenbaum - Partner, Co-Founder, Dovetail Consulting Group
- Gregory Moss - Chief Corporate Strategy, Legal Officer and Chief Complinace Officer, Evommune, Inc.
- Jennifer McGee - Senior Vice President, Global Chief Ethics and Compliance Officer, Otsuka Pharmaceutical Companies
- Michael Clarke, JD, CCEP - Vice President, Global Chief Compliance Officer, ConvaTec
10:15am - 10:45am30 mins
Networking and Refreshment Break
10:45am - 11:30am45 mins
Innovation Address — Behavior Science and How Pharma Should be Thinking About It
- Mark Lightowler, PhD - Founder and CEO, Phorix Limited
11:30am - 12:30pm60 mins
Keynote Enforcement Panel
- Emily Hodge - Partner, Choate, Hall & Stewart LLP
- Christopher Terranova - Senior Trial Counsel, Civil Division, Department of Justice
- Abraham George - Attorney, US Attorneys Office, District of Massachusetts
12:30pm - 2:00pm90 mins
Networking Luncheon
Networking Luncheon
12:30pm - 2:00pm90 mins
Closed-Door Luncheon
Closed-Door CCO and GC Luncheon Summit
2:00pm - 2:30pm30 mins
FDA Keynote Address — Hot Topics, Guidance and Enforcement
- Catherine Gray - Acting Director, Office of Prescription Drug Promotion, FDA
2:30pm - 3:15pm45 mins
Crisis Management Best Practices and Preparations
- Seth Lundy - Partner, King & Spalding
3:15pm - 3:45pm30 mins
Networking Break
3:45pm - 4:30pm45 mins
Small and Emerging Companies
Industry Playbook on Making the Most of Your Resources
- L. Kathleen Durosseau - Vice President, Chief Compliance Officer, Rigel Pharmaceuticals, Inc.
- Kelly Pitt - Vice President, U.S. General Counsel and U.S. Head of Compliance, MorphoSys US Inc.
3:45pm - 4:30pm45 mins
Mid to Large-Size Companies
Infusing Innovation into Compliance
- John Poulin - Partner and CTO, Helio Group
- Bjoern Dupre - Director, Compliance Monitoring and Investigations, Bayer
- Daniel Front - Director, Compliance Investigations & Privacy Compliance Department, Daiichi Sankyo, Inc.
3:45pm - 4:30pm45 mins
Medical Device Companies
State of the Industry on New and Emerging Risks
- Sujata Dayal - Vice President & Global Chief Compliance Officer, Medline Industries
4:30pm - 5:15pm45 mins
Small and Emerging Companies
Product Launch Considerations —Creating a Pre-Commercial Compliance Checklist
- Alison Fethke - Counsel, Health Care, Ropes & Gray LLP
- Kays Sawaged, MBA, CCEP, CFE - Director, Compliance & Ethics, BioXcel Therapeutics
- Holly Kramen - Chief Compliance Officer and Associate General Counsel, Iveric Bio
4:30pm - 5:15pm45 mins
Mid to Large-Size Companies
Novel Approaches to Integrate and Embed Compliance
- Cindy Cetani - SVP, Chief Integrity & Compliance Officer, Indivior
4:30pm - 5:15pm45 mins
Medical Device Companies
Transparency & Aggregate Spend Reporting
- Chelsea Ott - Director, Global Regulatory, MedPro Compliance Advisory Services, MedPro Systems, LLC
5:15pm - 6:15pm60 mins
Close of Day One and Networking Reception
Choose Day